Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000129006 | SCV000172902 | uncertain significance | Hereditary cancer-predisposing syndrome | 2012-12-28 | criteria provided, single submitter | clinical testing | This alteration is predicted to be benign with a score of 0.001 (sensitivity: 0.99; specificity: 0.09)This alteration is predicted to be tolerated with a score of 0.250 (conservation: 1.95) |
Labcorp Genetics |
RCV002295282 | SCV002596830 | uncertain significance | Familial cancer of breast; Fanconi anemia complementation group J | 2022-07-23 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 140817). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces threonine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 918 of the BRIP1 protein (p.Thr918Ile). |